Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for INVO Fertility (IVF) over the last 10 years, with Q3 2025 value amounting to $1.2 million.

  • INVO Fertility's Other Operating Expenses changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 6714.04%. This contributed to the annual value of -$21.5 million for FY2024, which is 9035.6% down from last year.
  • Per INVO Fertility's latest filing, its Other Operating Expenses stood at $1.2 million for Q3 2025.
  • In the past 5 years, INVO Fertility's Other Operating Expenses registered a high of $15.9 million during Q1 2025, and its lowest value of -$21.6 million during Q4 2024.
  • Over the past 5 years, INVO Fertility's median Other Operating Expenses value was -$2431.0 (recorded in 2021), while the average stood at -$598387.5.
  • In the last 5 years, INVO Fertility's Other Operating Expenses plummeted by 8452546.28% in 2022 and then surged by 1671037.01% in 2025.
  • Over the past 5 years, INVO Fertility's Other Operating Expenses (Quarter) stood at -$11432.0 in 2021, then surged by 3276.89% to $363182.0 in 2022, then plummeted by 1802.99% to -$6.2 million in 2023, then crashed by 249.72% to -$21.6 million in 2024, then skyrocketed by 105.7% to $1.2 million in 2025.
  • Its Other Operating Expenses stands at $1.2 million for Q3 2025, versus $2.5 million for Q2 2025 and $15.9 million for Q1 2025.